AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Vickers, SP Easton, N Malcolm, CS Allen, NH Porter, RH Bickerdike, MJ Kennett, GA
Citation: Sp. Vickers et al., Modulation of 5-HT2A receptor-mediated head-twitch behaviour in the rat by5-HT2C receptor agonists, PHARM BIO B, 69(3-4), 2001, pp. 643-652

Authors: Wood, MD Reavill, C Trail, B Wilson, A Stean, T Kennett, GA Lightowler, S Blackburn, TP Thomas, D Gager, TL Riley, G Holland, V Bromidge, SM Forbes, IT Middlemiss, DN
Citation: Md. Wood et al., SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety, NEUROPHARM, 41(2), 2001, pp. 186-199

Authors: Vickers, SP Dourish, CT Kennett, GA
Citation: Sp. Vickers et al., Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors, NEUROPHARM, 41(2), 2001, pp. 200-209

Authors: Stanhope, KJ Mirza, NR Bickerdike, MJ Bright, JL Harrington, NR Hesselink, MB Kennett, GA Lightowler, S Sheardown, MJ Syed, R Upton, RL Wadsworth, G Weiss, SM Wyatt, A
Citation: Kj. Stanhope et al., The muscarinic receptor agonist xanomeline has an anti psychotic-like profile in the rat, J PHARM EXP, 299(2), 2001, pp. 782-792

Authors: Bromidge, SM Dabbs, S Davies, S Duckworth, DM Forbes, IT Jones, GE Jones, J King, FD Saunders, DV Blackburn, TP Holland, V Kennett, GA Lightowler, S Middlemiss, DN Riley, GJ Trail, B Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroaryloxy)heteroaryl]carbamoyl]indolines: Novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolyticagents, BIOORG MED, 10(16), 2000, pp. 1863-1866

Authors: Bromidge, SM Davies, S Duckworth, DM Forbes, IT Jones, GE Jones, J King, FD Blackburn, TP Holland, V Kennett, GA Lightowler, S Middlemiss, DN Riley, GJ Trail, B Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orallyactive 5-HT2C receptor inverse agonists, BIOORG MED, 10(16), 2000, pp. 1867-1870

Authors: Bromidge, SM Dabbs, S Davies, DT Davies, S Duckworth, DM Forbes, IT Gaster, LM Ham, P Jones, GE King, FD Mulholland, KR Saunders, DV Wyman, PA Blaney, FE Clarke, SE Blackburn, TP Holland, V Kennett, GA Lightowler, S Middlemiss, DN Trail, B Riley, GJ Wood, MD
Citation: Sm. Bromidge et al., Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent, J MED CHEM, 43(6), 2000, pp. 1123-1134

Authors: Vickers, SP Benwell, KR Porter, RH Bickerdike, MJ Kennett, GA Dourish, CT
Citation: Sp. Vickers et al., Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity inrats, BR J PHARM, 130(6), 2000, pp. 1305-1314

Authors: Bromidge, SM Dabbs, S Davies, DT Davies, S Duckworth, DM Forbes, IT Gadre, A Ham, P Jones, GE King, FD Saunders, DV Thewlis, KM Vyas, D Blackburn, TP Holland, V Kennett, GA Riley, GJ Wood, MD
Citation: Sm. Bromidge et al., Model studies on a synthetically facile series of N-substituted phenyl-N '-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists, BIO MED CH, 7(12), 1999, pp. 2767-2773

Authors: Kennett, GA Trail, B Bright, F
Citation: Ga. Kennett et al., Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated, NEUROPHARM, 37(12), 1998, pp. 1603-1610
Risultati: 1-10 |